Tenet receives $32 price target — 3 facts

Analysts gave Dallas-based Tenet Healthcare a $32 price target, according to Realist Investor.

Advertisement

Here are three facts:

1. Based on 11 stock opinions, Tenet’s rating score is currently 1.93.

2. For the fiscal year 2016, Tenet has estimated earnings per share of $1.59.

3. In other news, Tenet added two independent directors to its board of directors: John P. Byrnes and Peter M. Wilver.

More articles on surgery centers:
12 new ASCs in October 2016
3 recent ASC acquisitions — November 4, 2016
How physicians and hospitals can benefit from joint ventures

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.